GKB Ophthalmics
Gkb Ophthalmics Performance
Day Range
- Low 84
- High 90.9
52 Week Range
- Low 0
- High 90.9
- Open Price84.5
- Previous Close88.4
- Volume83081
Start SIP in GKB Ophthalmics
Start SIPGkb Ophthalmics Investment Rating
-
Master Rating:
-
Gkb Ophthalmics has an operating revenue of Rs. 79.90 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 0% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 9% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 11 which is a POOR score indicating inconsistency in earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 108 indicates it belongs to a poor industry group of Medical-Products and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 10 | 6 | 7 | 7 | 8 | 7 |
Operating Expenses Qtr Cr | 9 | 7 | 8 | 7 | 7 | 7 |
Operating Profit Qtr Cr | 1 | -1 | -1 | 0 | 1 | 0 |
Depreciation Qtr Cr | 1 | 2 | 0 | 0 | 0 | 1 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Net Profit Qtr Cr | 0 | -2 | 0 | -1 | 0 | -1 |
Gkb Ophthalmics Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹98.05
- 50 Day
- ₹94.99
- 100 Day
- ₹97.22
- 200 Day
- ₹101.39
- 20 Day
- ₹98.01
- 50 Day
- ₹91.27
- 100 Day
- ₹94.88
- 200 Day
- ₹109.71
Gkb Ophthalmics Resistance and Support
Resistance | |
---|---|
First Resistance | ₹102.19 |
Second Resistance | ₹104.54 |
Third Resistance | ₹107.13 |
RSI | 55.63 |
MFI | 80.91 |
MACD Single Line | 3.1 |
MACD | 2.69 |
Support | |
---|---|
First Resistance | ₹97.25 |
Second Resistance | ₹94.66 |
Third Resistance | ₹92.31 |
Gkb Ophthalmics Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 2,193 | 154,102 | 70.27 |
Week | 2,259 | 165,201 | 73.13 |
1 Month | 7,670 | 575,061 | 74.98 |
6 Month | 6,982 | 534,391 | 76.54 |
Gkb Ophthalmics Result Highlights
GKB Ophthalmics Synopsis
BSE-Medical-Products
Gkb Ophthalmic is involved in the business activities of Manufacture of ophthalmic goods, eyeglasses, sunglasses, lenses ground to prescription, contact lenses, safety goggles etc.. Company’s Total Operating Revenue is Rs. 27.73 Cr. and Equity Capital is Rs. 5.04 Cr. for the Year ended 31/03/2023. GKB Ophthalmics Ltd. is a Public Limited Listed company incorporated on 10/12/1981 and has its registered office in the State of Goa, India. Company’s Corporate Identification Number(CIN) is L26109GA1981PLC000469 and registration number is 000469.Market Cap | 50 |
Sales | 30 |
Shares in Float | 0.21 |
No of funds | 2 |
Yield |
Book Value | 1.83 |
U/D Vol ratio | 1.9 |
LTDebt / Equity | 4 |
Alpha | 0.1 |
Beta | 0.67 |
GKB Ophthalmics
Owner Name | Jun-23 | Mar-23 | Dec-22 | Sep-22 |
---|---|---|---|---|
Promoters | 59.18% | 59.09% | 59.09% | 59.16% |
Foreign Portfolio Investors | 1.79% | 1.79% | 1.98% | 1.98% |
Individual Investors | 27.39% | 27.11% | 24.8% | 24.82% |
Others | 11.64% | 12.01% | 14.13% | 14.04% |
GKB Ophthalmics Management
Name | Designation |
---|---|
Mr. K G Gupta | Chairman & Managing Director |
Mr. Vikram Gupta | Director |
Mr. Anil Palekar | Director |
Mr. Subhash Redkar | Director |
Mrs. Shashi Kumar Katreddi | Director |
Gkb Ophthalmics Forecast
Price Estimates
Gkb Ophthalmics Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-08-11 | Quarterly Results | |
2023-05-30 | Audited Results | |
2023-02-14 | Quarterly Results | |
2022-08-12 | Quarterly Results | |
2022-05-30 | Audited Results |
- Company Name
- CMP
- Chg(%)
- Cipla
- 1179
- 1.3
- Dr Reddys Labs
- 5530
- 1.1
- LTIMindtree
- 5411
- 0.9
- Divis Lab.
- 3784
- 0.8
- Sun Pharma.Inds.
- 1131
- 0.5
- Company Name
- CMP
- Chg(%)
- Bajaj Finance
- 7752
- -1.5
- Tata Steel
- 127
- -1.4
- ICICI Bank
- 936
- -1.3
- B P C L
- 348
- -1.2
- Grasim Inds
- 1935
- -1.2
GKB Ophthalmics FAQs
What is Share Price of GKB Ophthalmics ?
GKB Ophthalmics share price is ₹99 As on 27 September, 2023 | 10:39
What is the Market Cap of GKB Ophthalmics ?
The Market Cap of GKB Ophthalmics is ₹49.9 Cr As on 27 September, 2023 | 10:39
What is the P/E ratio of GKB Ophthalmics ?
The P/E ratio of GKB Ophthalmics is -31.6 As on 27 September, 2023 | 10:39
What is the PB ratio of GKB Ophthalmics ?
The PB ratio of GKB Ophthalmics is 0.7 As on 27 September, 2023 | 10:39